Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
Notwendige Cookies
Diese Cookies sind für das Funktionieren des Logins und die Speicherung der Cookie-Einstellungen erforderlich und können deshalb nicht deaktiviert werden.
Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
These shares are having a strong session on Thursday. But why?
The post Why DroneShield, Neuren, Paradigm, and Pilbara Minerals shares are roaring higher today appeared first on The Motley Fool Australia....
The broker described Neuren as a standout in the ASX biotech sector.
The post Macquarie initiates coverage of Neuren Pharmaceuticals shares; forecasts 45% upside appeared first on The Motley Fool Australia....
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares have been on form over the past 12 months. During this …
The post Why does Macquarie think Fisher & Paykel shares are a buy? appeared first on The Motley Fool Australia....
These shares are having a tough time on hump day. But why?
The post Why ALS, Fisher & Paykel Healthcare, IPD, and Predictive Discovery shares are falling today appeared first on The Motley Fool Australia....
These shares are having a better day than most today. But why?
The post Why Boss Energy, Neuren, Strickland, and Vulcan shares are pushing higher today appeared first on The Motley Fool Australia....
Will the ASX 200 healthcare stock continue to outperform?
The post Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result? appeared first on The Motley Fool Australia....
Oceania Healthcare and Summerset could quietly emerge as high-upside plays for patient ASX investors.
The post Why Macquarie thinks the NZ retirement village sector could be an emerging opportunity for ASX investors appeared first on The Motley Fool Australia....
These shares are having a tough finish to the week. But why?
The post Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today appeared first on The Motley Fool Australia....
These shares are starting the week on a high. But why?
The post Why DroneShield, Fiducian, Neuren, and Newmont shares are storming higher appeared first on The Motley Fool Australia....
Let's see which of these two names could be best buys.
The post Should I buy Fisher & Paykel or ResMed shares? appeared first on The Motley Fool Australia....
These shares are avoiding the market weakness on Thursday. But why?
The post Why Core Lithium, Healius, Neuren, and Reject Shop shares are storming higher today appeared first on The Motley Fool Australia....
CANBERA (dpa-AFX) - Esperion Therapeutics (ESPR), Monday announced that it has entered into a license and distribution agreement with CSL Seqirus (CSL) to exclusively commercialize NEXLETOL and NE......
These shares are having a strong session on Thursday. What's going on?
The post Why Eagers, Medibank, Neuren, and Qantas shares are jumping today appeared first on The Motley Fool Australia....
These shares are starting the week on a positive note. But why?
The post Why APA, Aussie Broadband, Neuren, and NIB shares are charging higher today appeared first on The Motley Fool Australia....